Royal Bank Of Canada initiated coverage on shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $17.00 price target on the software maker’s stock.

MDRX has been the topic of several other reports. Jefferies Group LLC set a $17.00 price objective on shares of Allscripts Healthcare Solutions and gave the company a buy rating in a report on Friday, August 25th. BidaskClub upgraded shares of Allscripts Healthcare Solutions from a strong sell rating to a sell rating in a report on Tuesday, June 13th. Maxim Group restated a buy rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, August 4th. Cowen and Company upgraded shares of Allscripts Healthcare Solutions from a market perform rating to an outperform rating and boosted their price target for the stock from $13.00 to $16.00 in a research note on Monday, September 11th. Finally, Piper Jaffray Companies reiterated a hold rating and set a $14.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $14.94.

Allscripts Healthcare Solutions (MDRX) opened at 13.73 on Tuesday. The stock’s market cap is $2.48 billion. Allscripts Healthcare Solutions has a 1-year low of $9.80 and a 1-year high of $13.97. The company has a 50-day moving average of $13.01 and a 200 day moving average of $12.40.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.04). The company had revenue of $426.10 million during the quarter, compared to analysts’ expectations of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 earnings per share. Analysts predict that Allscripts Healthcare Solutions will post $0.62 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Coverage Initiated at Royal Bank Of Canada” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.dailypolitical.com/2017/09/23/allscripts-healthcare-solutions-inc-mdrx-coverage-initiated-at-royal-bank-of-canada.html.

In other news, CEO Paul Black sold 15,000 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $202,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Farley sold 5,000 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the completion of the sale, the executive vice president now directly owns 196,607 shares of the company’s stock, valued at $2,658,126.64. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $473,800 over the last ninety days. 0.75% of the stock is currently owned by corporate insiders.

Several hedge funds have recently bought and sold shares of MDRX. FNY Partners Fund LP boosted its holdings in shares of Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock valued at $101,000 after acquiring an additional 7,200 shares during the period. Invictus RG acquired a new stake in shares of Allscripts Healthcare Solutions in the first quarter valued at approximately $105,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Allscripts Healthcare Solutions by 9.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock valued at $120,000 after acquiring an additional 816 shares during the period. Bank of Montreal Can boosted its holdings in shares of Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after acquiring an additional 3,724 shares during the period. Finally, Virtu Financial LLC acquired a new stake in shares of Allscripts Healthcare Solutions in the second quarter valued at approximately $134,000.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.